MedPath

EVKEEZA

EVKEEZA

Approved
DIN Number

02541769

Drug Class

Human

Market Date

Nov 21, 2023

Company
HC

ULTRAGENYX PHARMACEUTICAL INC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02541769
AIG Number0165041001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
C10AX17 EVINACUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:06.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

EVINACUMABActive
Strength: 150 MG / ML
Monograph: EVINACUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.